TY - JOUR
T1 - Post-donation SARS-CoV-2 identification among Thai blood donors
AU - Intharasongkroh, Duangnapa
AU - Wongkijpatana, Kamin
AU - Kongsup, Aumnad
AU - Nontapaoraya, Aranya
AU - Chaiwong, Kriangsak
AU - Oota, Sineenart
AU - Peunpa, Jiratchaya
AU - Vongpunsawad, Sompong
AU - Manopwisedjaroen, Suwimon
AU - Thitithanyanont, Arunee
AU - Poovorawan, Yong
AU - Kupatawintu, Pawinee
AU - Chiewsilp, Pimol
AU - Chaiwanichsiri, Dootchai
N1 - Publisher Copyright:
© 2023, Thai Red Cross Society National Blood Center. All rights reserved.
PY - 2023/10/1
Y1 - 2023/10/1
N2 - Introduction: Asymptomatic and mildly symptomatic individuals with COVID-19 may inadvertently donate blood because the COVID-19 screening test is not a prerequisite for blood donation. Although previous studies suggested that the risk of transfusion-transmitted COVID-19 is minimal, monitoring and evaluating the likelihood of SARS-CoV-2 transmission from transfusion remain important. Objective: To determine the potential risk of transfusion-transmitted SARS-CoV-2 infection. Materials and Methods: During the peak circulation of the SARS-CoV-2 Delta variant in Thailand from April to December 2021, the National Blood Centre collected blood from 448,025 donors; 158 donors (0.035%) self-reported a COVID-19 positive diagnosis either by the antigen test kit or by PCR within 7 days post-donation. Only 88 donor plasma samples available for testing were subjected to viral RNA detection by using the COBAS SARS-CoV-2 RNA assay. Further confirmatory testing of the positive samples with additional real-time reverse-transcription polymerase chain reaction (rRT-PCR) for the viral genome and sub-genome was performed. Results: One sample consistently tested positive for the ORF1a/b and the E gene on the COBAS, while four other samples were positive for either gene. All five samples (from donors 27-60 years of age) were negative upon re-testing with other assays for the viral genome and sub-genome. Two patients were uneventfully transfused with the blood components derived from this donor. Conclusion: Available data to date, including our study, suggested that SARS-CoV-2 transmission through transfusion was unlikely.
AB - Introduction: Asymptomatic and mildly symptomatic individuals with COVID-19 may inadvertently donate blood because the COVID-19 screening test is not a prerequisite for blood donation. Although previous studies suggested that the risk of transfusion-transmitted COVID-19 is minimal, monitoring and evaluating the likelihood of SARS-CoV-2 transmission from transfusion remain important. Objective: To determine the potential risk of transfusion-transmitted SARS-CoV-2 infection. Materials and Methods: During the peak circulation of the SARS-CoV-2 Delta variant in Thailand from April to December 2021, the National Blood Centre collected blood from 448,025 donors; 158 donors (0.035%) self-reported a COVID-19 positive diagnosis either by the antigen test kit or by PCR within 7 days post-donation. Only 88 donor plasma samples available for testing were subjected to viral RNA detection by using the COBAS SARS-CoV-2 RNA assay. Further confirmatory testing of the positive samples with additional real-time reverse-transcription polymerase chain reaction (rRT-PCR) for the viral genome and sub-genome was performed. Results: One sample consistently tested positive for the ORF1a/b and the E gene on the COBAS, while four other samples were positive for either gene. All five samples (from donors 27-60 years of age) were negative upon re-testing with other assays for the viral genome and sub-genome. Two patients were uneventfully transfused with the blood components derived from this donor. Conclusion: Available data to date, including our study, suggested that SARS-CoV-2 transmission through transfusion was unlikely.
KW - Blood donors
KW - COVID-19
KW - SARS-CoV-2 RNA
UR - https://www.scopus.com/pages/publications/105054297961
M3 - Article
AN - SCOPUS:105054297961
SN - 2985-2390
VL - 33
SP - 251
EP - 259
JO - Journal of Hematology and Transfusion Medicine
JF - Journal of Hematology and Transfusion Medicine
IS - 4
ER -